BACKGROUND: Many preventive interventions for mental disorders have costs and benefits that spill over to sectors outside the healthcare sector. Little is known about these "inter-sectoral costs and benefits" (ICBs) of prevention. However, to achieve an efficient allocation of scarce resources, insights on ICBs are indispensable. AIM OF THE STUDY: The main aim was to identify the ICBs related to the prevention of mental disorders and provide a sector-specific classification scheme for these ICBs. METHODS: Using PubMed, a literature search was conducted for ICBs of mental disorders and related (psycho)social effects. A policy perspective was used to build the scheme's structure, which was adapted to the outcomes of the literature search. In order to validate the scheme's international applicability inside and outside the mental health domain, semi-structured interviews were conducted with (inter)national experts in the broad fields of health promotion and disease prevention. RESULTS: The searched-for items appeared in a total of 52 studies. The ICBs found were classified in one of four sectors: "Education", "Labor and Social Security", "Household and Leisure" or "Criminal Justice System". Psycho(social) effects were placed in a separate section under "Individual and Family". Based on interviews, the scheme remained unadjusted, apart from adding a population-based dimension. DISCUSSION: This is the first study which offers a sector-specific classification of ICBs. Given the explorative nature of the study, no guidelines on sector-specific classification of ICBs were available. Nevertheless, the classification scheme was acknowledged by an international audience and could therefore provide added value to researchers and policymakers in the field of mental health economics and prevention. IMPLICATIONS FOR HEALTH POLICIES: The identification and classification of ICBs offers decision makers supporting information on how to optimally allocate scarce resources with respect to preventive interventions for mental disorders. IMPLICATIONS FOR FURTHER RESEARCH: By exploring a new area of research, which has remained largely unexplored until now, the current study has an added value as it may form the basis for the development of a tool which can be used to calculate the ICBs of specific mental health related preventive interventions.
BACKGROUND: Many preventive interventions for mental disorders have costs and benefits that spill over to sectors outside the healthcare sector. Little is known about these "inter-sectoral costs and benefits" (ICBs) of prevention. However, to achieve an efficient allocation of scarce resources, insights on ICBs are indispensable. AIM OF THE STUDY: The main aim was to identify the ICBs related to the prevention of mental disorders and provide a sector-specific classification scheme for these ICBs. METHODS: Using PubMed, a literature search was conducted for ICBs of mental disorders and related (psycho)social effects. A policy perspective was used to build the scheme's structure, which was adapted to the outcomes of the literature search. In order to validate the scheme's international applicability inside and outside the mental health domain, semi-structured interviews were conducted with (inter)national experts in the broad fields of health promotion and disease prevention. RESULTS: The searched-for items appeared in a total of 52 studies. The ICBs found were classified in one of four sectors: "Education", "Labor and Social Security", "Household and Leisure" or "Criminal Justice System". Psycho(social) effects were placed in a separate section under "Individual and Family". Based on interviews, the scheme remained unadjusted, apart from adding a population-based dimension. DISCUSSION: This is the first study which offers a sector-specific classification of ICBs. Given the explorative nature of the study, no guidelines on sector-specific classification of ICBs were available. Nevertheless, the classification scheme was acknowledged by an international audience and could therefore provide added value to researchers and policymakers in the field of mental health economics and prevention. IMPLICATIONS FOR HEALTH POLICIES: The identification and classification of ICBs offers decision makers supporting information on how to optimally allocate scarce resources with respect to preventive interventions for mental disorders. IMPLICATIONS FOR FURTHER RESEARCH: By exploring a new area of research, which has remained largely unexplored until now, the current study has an added value as it may form the basis for the development of a tool which can be used to calculate the ICBs of specific mental health related preventive interventions.
Authors: Christian Brettschneider; Alexander Konnopka; Hannah König; Alexander Rommel; Julia Thom; Christian Schmidt; Hans-Helmut König Journal: Pharmacoeconomics Date: 2021-02-01 Impact factor: 4.981
Authors: Ghislaine Apg van Mastrigt; Aggie Tg Paulus; Marie-Jeanne Aarts; Silvia Maa Evers; Adrienne Fg Alayli-Goebbels Journal: BMC Public Health Date: 2015-09-24 Impact factor: 3.295
Authors: Pim Wetzelaer; Joan Farrell; Silvia M A A Evers; Gitta A Jacob; Christopher W Lee; Odette Brand; Gerard van Breukelen; Eva Fassbinder; Heather Fretwell; R Patrick Harper; Anna Lavender; George Lockwood; Ioannis A Malogiannis; Ulrich Schweiger; Helen Startup; Teresa Stevenson; Gerhard Zarbock; Arnoud Arntz Journal: BMC Psychiatry Date: 2014-11-18 Impact factor: 3.630
Authors: Ruben M W A Drost; Aggie T G Paulus; Astrid F Jander; Liesbeth Mercken; Hein de Vries; Dirk Ruwaard; Silvia M A A Evers Journal: J Med Internet Res Date: 2016-04-21 Impact factor: 5.428
Authors: Susanne Mayer; Aggie T G Paulus; Agata Łaszewska; Judit Simon; Ruben M W A Drost; Dirk Ruwaard; Silvia M A A Evers Journal: Pharmacoeconomics Date: 2017-09 Impact factor: 4.981
Authors: Robbin H Ophuis; Joran Lokkerbol; Juanita A Haagsma; Mickaël Hiligsmann; Silvia M A A Evers; Suzanne Polinder Journal: PLoS One Date: 2018-11-07 Impact factor: 3.240
Authors: Irina Pokhilenko; Luca M M Janssen; Silvia M A A Evers; Ruben M W A Drost; Lena Schnitzler; Aggie T G Paulus Journal: Pharmacoeconomics Date: 2021-06-14 Impact factor: 4.981
Authors: Henny J Wansink; Ruben M W A Drost; Aggie T G Paulus; Dirk Ruwaard; Clemens M H Hosman; Jan M A M Janssens; Silvia M A A Evers Journal: BMC Health Serv Res Date: 2016-07-07 Impact factor: 2.655